TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma

Abstract Rhabdomyosarcoma (RMS), such as other childhood tumors, has witnessed treatment advancements in recent years. However, high-risk patients continue to face poor survival rates, often attributed to the presence of the PAX3/7-FOXO1 fusion proteins, which has been associated with metastasis and...

Descrición completa

Detalles Bibliográficos

Principais autores:	Gabriel Gallo-Oller, Guillem Pons, Júlia Sansa-Girona, Natalia Navarro, Patricia Zarzosa, Lia García-Gilabert, Paula Cabré-Fernandez, Gabriela Guillén Burrieza, Lorena Valero-Arrese, Miguel F. Segura, José M. Lizcano, José Sánchez de Toledo, Lucas Moreno, Soledad Gallego, Josep Roma
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-04-01
Series:	Experimental Hematology & Oncology
Assuntos:	TRIB3 Fusion protein PAX3-FOXO1 Akt Rhabdomyosarcoma
Acceso en liña:	https://doi.org/10.1186/s40164-024-00503-9
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!